Literature DB >> 24408063

Comparison of neutrophil to lymphocyte ratio in patients with coronary artery ectasia versus patients with obstructive coronary artery disease.

Ezgi Kalaycıoğlu1, Tayyar Gökdeniz, Ahmet Cağrı Aykan, Ilker Gül, Faruk Boyacı, Ozan Mustafa Gürsoy, Erdal Belen, Sükrü Celik.   

Abstract

BACKGROUND: Previous studies have demonstrated that inflammation, neurohormonal process and cardiovascular risk factors are associated with the development of coronary artery ectasia (CAE). However, the underlying mechanisms responsible for ectasia formation are not fully understood. The neutrophil to lymphocyte (N/L) ratio has recently emerged as a new inflammation marker for cardiovascular disease. AIM: In this study, we hypothesised that CAE could be associated with more severe inflammation compared to obstructive coronary artery disease (O-CAD) with regard to N/L ratio values.
METHODS: A total of 405 patients with isolated CAE, O-CAD and insignificant CAD (controls) were enrolled. Severity of isolated CAE was determined according to the Markis classification. N/L ratio values were compared between the three groups.
RESULTS: We determined that the patients with isolated CAE had significantly elevated N/L ratio values compared to O-CAD and control groups (2.5 vs. 1.9, p < 0.001 and vs. 1.6, p < 0.001, respectively). In multivariate analysis adjusted for age, sex, diabetes mellitus (DM) and hypertension, N/L ratio was independently associated with the presence (N/L ratio, OR = 2.48, 95% CI 2.03-3.02, p < 0. 001) and severity (DM, OR = 2.90, 95% CI 1.02-8.18, p = 0.044, N/L ratio, OR = 1.88, 95% CI 1.47-2.41, p = 0.004) of isolated CAE. ROC curve analysis revealed that a N/L ratio value of > 2.06 identified the patients with isolated CAE.
CONCLUSIONS: We showed that patients with isolated CAE had a significantly higher N/L ratio than patients with O-CAD and control groups. This finding suggests that a more severe inflammatory process could be involved in the development of CAE.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24408063     DOI: 10.5603/KP.a2013.0349

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  6 in total

Review 1.  Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis.

Authors:  Dimitrios A Vrachatis; Konstantinos A Papathanasiou; Dimitrios Kazantzis; Jorge Sanz-Sánchez; Sotiria G Giotaki; Konstantinos Raisakis; Andreas Kaoukis; Charalampos Kossyvakis; Gerasimos Deftereos; Bernhard Reimers; Dimitrios Avramides; Gerasimos Siasos; Michael Cleman; George Giannopoulos; Alexandra Lansky; Spyridon Deftereos
Journal:  Diagnostics (Basel)       Date:  2022-04-19

2.  Usefulness of Neutrophil to Lymphocyte Ratio in Prediction of Coronary Artery Lesions in Patients with Kawasaki Disease.

Authors:  Fikri Demir; Cem Karadeniz; Rahmi Özdemir; Yılmaz Yozgat; Kübra Çelegen; Utku Karaaslan; Mustafa Demirol; Timur Meşe; Nurettin Ünal
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

3.  Author`s Reply.

Authors:  Ahmet Çağrı Aykan
Journal:  Anatol J Cardiol       Date:  2016-07       Impact factor: 1.596

4.  Hypertension and coronary artery ectasia: a systematic review and meta-analysis study.

Authors:  Mostafa Bahremand; Ehsan Zereshki; Behzad Karami Matin; Mansour Rezaei; Hamidreza Omrani
Journal:  Clin Hypertens       Date:  2021-07-15

5.  Neutrophil-to-lymphocyte ratio may be a marker of peripheral artery disease complexity.

Authors:  Ahmet Çağrı Aykan; Engin Hatem; Ezgi Kalaycıoğlu; Can Yücel Karabay; Regayip Zehir; Tayyar Gökdeniz; Duygun Altıntaş Aykan; Şükrü Çelik
Journal:  Anatol J Cardiol       Date:  2015-11-26       Impact factor: 1.596

6.  Anti-inflammatory effects of rosuvastatin treatment on coronary artery ectasia patients of different age groups.

Authors:  Cheng-Hui Fan; Ying Hao; Yong-Hua Liu; Xiao-Lin Li; Zhen-Hao Huang; Yu Luo; Rui-Lin Li
Journal:  BMC Cardiovasc Disord       Date:  2020-07-11       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.